New fund helps patients cover IgG4-RD treatment cost
A new program aims to support people with immunoglobulin G4-related disease (IgG4-RD) and their families by helping cover out-of-pocket medical costs associated with treatment. The Assistance Fund (TAF) launched the program to help eligible patients with costs including copayments, health insurance premiums, and incidental medical expenses. “For people…

